• Certified Lab Equipment & Reagents
  • Fast Dispatch on In-Stock Items
  • Expert Scientific Support

Product details

Recombinant Human TNFRSF17/BCMA Protein (Fc Tag)

Catalog number PKSH031502-01

Selecting a variant updates its price, size and availability.

Price for PKSH031502-01

Sign In for Pricing

Size / count 100 µg

Specifications

Catalog number
PKSH031502-01
Size / count
100 µg
Dry ice
No
Hazardous
No
Discontinued
No
Background
Tumor necrosis factor receptor superfamily, member 17 (TNFRSF17), also known as B cell maturation antigen (BCMA) or CD269 antigen, is a member of the TNF-receptor superfamily. This receptor is preferentially expressed in mature B lymphocytes, and may be important for B cell development and autoimmune response. This receptor has been shown to specifically bind to the tumor necrosis factor (ligand) superfamily, member 13b (TNFSF13BBAFF), and to lead to NF-kappaB and MAPK8/JNK activation. TNFRSF17/BCMA/CD269 also binds to various TRAF family members, and thus may transduce signals for cell survival and proliferation. TNFRSF17/BCMA/CD269 is a receptor for TALL-1 and BCMA activates NF-kappaB through a TRAF5-, TRAF6-, NIK-, and IKK-dependent pathway. The identification of TNFRSF17 as a NF-kappaB-activating receptor for TALL-1 suggests molecular targets for drug development against certain immunodeficient or autoimmune diseases. TNFRSF17/BCMA is a target of donor B-cell immunity in patients with myeloma who respond to DLI. Antibody responses to cell-surface BCMA may contribute directly to tumor rejection in vivo.
Synonyms
BCM; BCMA; CD269; TNFRSF13A
UniProt
Q02223
Accession Number
NP_001183.2
Expression System
HEK293 Cells
Tag
N-rFc
Sequence
Met 1-Ala54
Field of Research
Signal Transduction; Cancer; immunology
Endotoxin
< 1.0 EU per μg of the protein as determined by the LAL method.
Purity
> 95 % as determined by reducing SDS-PAGE.
Bioactivity
Not validated for activity
Reconstitution
Please refer to the printed manual for detailed information.
Shipping Conditions
This product is provided as lyophilized powder which is shipped with ice packs.
Storage Conditions
Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80°C. Reconstituted protein solution can be stored at 4-8°C for 2-7 days. Aliquots of reconstituted samples are stable at < -20°C for 3 months.
Calculated Molecular Weight
33.3 kDa
Species
Human

Frequently Asked Questions

What is the catalog number for Recombinant Human TNFRSF17/BCMA Protein (Fc Tag)?

The catalog number for Recombinant Human TNFRSF17/BCMA Protein (Fc Tag) is PKSH031502.

What sizes are available for Recombinant Human TNFRSF17/BCMA Protein (Fc Tag)?

Recombinant Human TNFRSF17/BCMA Protein (Fc Tag) is available in the following size(s): 100 µg, 1 mg.

How many pack sizes does Recombinant Human TNFRSF17/BCMA Protein (Fc Tag) come in?

Recombinant Human TNFRSF17/BCMA Protein (Fc Tag) is available in 2 different pack sizes.

Is Recombinant Human TNFRSF17/BCMA Protein (Fc Tag) in stock?

Recombinant Human TNFRSF17/BCMA Protein (Fc Tag) is currently made to order / not held in immediate stock. Contact us for lead time.

Who manufactures Recombinant Human TNFRSF17/BCMA Protein (Fc Tag)?

Recombinant Human TNFRSF17/BCMA Protein (Fc Tag) is manufactured by Elabscience.

What is the estimated delivery time for Recombinant Human TNFRSF17/BCMA Protein (Fc Tag)?

Estimated delivery time for Recombinant Human TNFRSF17/BCMA Protein (Fc Tag) is approximately 15 business day(s), depending on your location.

Where can I find the safety data sheet (SDS/MSDS) for Recombinant Human TNFRSF17/BCMA Protein (Fc Tag)?

The safety data sheet for Recombinant Human TNFRSF17/BCMA Protein (Fc Tag) is available here: https://789.bio/eb/GCG48K.

What dilution range is recommended for immunohistochemistry (IHC) with this antibody?

A starting IHC dilution range is listed on the datasheet, but should be optimized for your specific tissue type and staining protocol.

Can I request a Safety Data Sheet (SDS) for this product?

Yes, safety data sheets are available for hazardous or chemically classified products and can be provided on request or downloaded from the product page.

Can this product be used for co-immunoprecipitation (Co-IP)?

Suitability for Co-IP depends on the specific antibody and is noted under validated applications on the datasheet. If it isn’t listed, contact our technical support team for guidance based on your target and sample type.

You Might Also Like
CD8 (RIV11), CF555 conjugate, 0.1mg/mL
CD8 (RIV11), CF555 conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC550333-500
TNF alpha (J2D10), CF405S conjugate, 0.1mg/mL
TNF alpha (J2D10), CF405S conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC040994-100
CD5 (Cris-1), CF740 conjugate, 0.1mg/mL
CD5 (Cris-1), CF740 conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC740176-500
Cytokeratin 10 (KRT10/844), CF488A conjugate, 0.1mg/mL
Cytokeratin 10 (KRT10/844), CF488A conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC880844-500
Vimentin (VM1170), CF647 conjugate, 0.1mg/mL
Vimentin (VM1170), CF647 conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC471170-500
CD27 (Tumor Necrosis Factor Receptor Superfamily 7) (rLPFS2/1611), CF405S conjugate, 0.1mg/mL
CD27 (Tumor Necrosis Factor Receptor Superfamily 7) (rLPFS2/1611), CF405S conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC041976-500
MCM7 (Proliferation Marker) (MCM7/1468), CF568 conjugate, 0.1mg/mL
MCM7 (Proliferation Marker) (MCM7/1468), CF568 conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC681468-500
Moesin (MSN/492), CF405S conjugate, 0.1mg/mL
Moesin (MSN/492), CF405S conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC040492-500